Diabetes eJournal 3-11 part 1

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
39 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Mar 30, 2011

CME/CE Information

Release Date: March 1, 2011
Expiration Date: March 1, 2012

Earning CME Credit
If you are interested in obtaining CME/CE credit for this session, please access the activity at http://www.ejournalclub.org/viewdiscussion.aspx?id=38. You will need to register and launch the activity prior to being able to complete the evaluation & posttest.

Accreditation Statement
DIME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
DIME designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Creditâ„¢. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Activity Purpose
To recognize the integral role of a lifestyle intervention, including diet and increased physical activity, for achieving weight loss and reducing cardiovascular risk factors in overweight or obese patients with type 2 diabetes mellitus
Target Audience
This activity is directed to endocrinologists, primary care physicians, internists, and other healthcare professionals who manage and treat patients with T2DM

Funding Statement
Diabetes eJournal Club is supported by an educational grant from Amylin Pharmaceuticals, Inc, and Lilly USA LLC.

Sponsorship
Diabetes eJournal Club is sponsored by DIME.

Faculty and Disclosures
DIME requires that all persons who were in a position to control or influence the content of this CME activity disclose all relevant financial relationships with any commercial interest. This information is used to: (1) determine whether a conflict exists, (2) resolve the conflict by initiating a content validation process, and (3) advise learners of this information.

Frank Svec, MD, PhD
Sources of Funding for Research: None
Consulting Agreements: None
Speakers Bureau/Honorarium Agreements: Novartis Pharmaceutical Corp
Financial Interest/Stock Ownership: None
Discussion of Off-Label, Investigational, or Experimental Drug Use: None

Rena R. Wing, PhD, has nothing to disclose

Nancy Moran has nothing to disclose

Inquiries
All inquiries should be directed to:
DIMEinfo@dimeded.org

© 2011 DIME

Category:

Education

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

All Comments

Adding comments has been disabled for this video.

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more